Hesitancy of Covid-19 Vaccination among Health Workers (other than Doctors) in a Tertiary Hospital in South-South, Nigeria
Asian Journal of Research in Infectious Diseases,
Background: Coronavirus Disease 2019 (COVID-19) is a disease of the respiratory system that is caused by the Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organisation on the 11th of March, 2020.
Objective: To assess the reasons behind the low turnout of health workers (other than doctors) for COVID-19 vaccination in the Federal Medical Centre, Yenagoa, Bayelsa State, Nigeria.
Materials and Methods: This study was carried out at the Federal Medical Centre, Yenagoa between 1st and 23rd April, 2021. It was a descriptive cross-sectional study. The study population consisted of 182 health workers (excluding doctors) from all departments/units in the hospital. The data were collected with a predesigned questionnaire, and were analysed using IBM SPSS 23.0 version.
Results: About three-quarter were females (74.7%), and close to half were aged ≤35 years (47.8%). The respondents were Nurses, Pharmacists, Medical laboratory scientists, and Non-clinical officers. Only 27.4% took the vaccine. Most of those who refused the vaccine did so because they wanted to see what would happen to those who received the vaccine (70.5%). Others felt the vaccine has not gone through enough clinical trials (62.1%).
Conclusion: In this study, there was very poor turnout of health workers for COVID-19 vaccination. The factors that influenced acceptance of the vaccine were mainly COVID-19 related features. These findings suggest that people who have had personal experiences with the disease have a better understanding of the gravity of the situation, and hence are more likely to accept vaccination against the disease.
- health workers
- COVID-19 vaccination
How to Cite
Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J. 2020;43(4):328- 333.
Wikipedia. Spanish flu. Available from: https://en.m.wikipedia.org/wiki/Spanish_flu Accessed May 13, 2021.
Allagoa DO, Oriji PC, Tekenah ES, Obagah L, Njoku C, Afolabi AS, Atemie G. Predictors of acceptance of Covid-19 vaccine among patients at a tertiary hospital in South-South Nigeria. Int J Community Med Public Health. 2021;8(5):2165–2172.
Oriji PC, Allagoa DO, Obagah L, Tekenah ES, Ohaeri, OS, Atemie G. Perception about Covid-19 vaccine among patients at the Federal Medical Centre, Yenagoa, South-South Nigeria. Int J Res Med Sci. 2021;9(5):1281–1287.
Amzat J, Aminu K, Kolo VI, Akinyele AA, Ogundairo JA, Danjibo MC. Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days. Int J Infect Dis. 2020;98:218-224.
Nigeria overview. Corona Tracker.
Available:https://www.coronatracker.com/country/nigeria/ Accessed May 13, 2021.
Kwok KO, Lai F, Wei WI, Wong SYS, Tang JW. Herd immunity–estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020;80(6):e32-e33.
Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press;2008.
Health Care. COVID-19 Vaccine Key to Reaching ‘Herd Immunity.
Available: https://www.muhealth.org/our-stories/covid-19-vaccine-key-reaching-herd-immunity Accessed May 13, 2021.
World Health Organization. Ten threats to global health.
Available: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 Accessed May 13, 2021.
GAVI – the vaccine alliance. The COVID-19 vaccine race – weekly update.
Available:https://www.gavi.org/vaccineswork/covid-19-vaccine-race. Accessed May 13, 2021.
Wego travel blog. COVAX explained: What you need to know about COVID-19 vaccine global access.
Available: https://blog.wego.com/covax-explained/ Accessed May 13, 2021.
Araoye MO. Subjects Selection. In: Research Methodology with statistics for Health and Social sciences. Ilorin, Nigeria: Nathadex publishers, 2003;115–129.
Piltch-Loeb R, DiClemente R. The vaccine uptake continuum: applying social science theory to shift vaccine hesitancy. Vaccines. 2020;8(1):76–82.
Fine P, Eames K, Heymann DL. “Herd immunity”: A rough guide. Clin Infect Dis. 2021; 52(7):911-916.
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495.
DOI: 10.1016/j.eclinm.2020.100495. Accessed May 13, 2021
Lazarus JV, Ratzan SC, Palayew A. Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27, 225–228.
Available: https://doi.org/10.1038/s41591-020-1124-9 Accessed May 13, 2021.
Olomofe CO, Soyemi KV, Udomah BF, Owolabi AO, Ajumuka EE, Igbokwe MC, et al. Predictors of uptake of a potential Covid-19 vaccine among Nigerian adults. J Vaccines Vaccin. 2021;12(1):442– 445.
Thunstrom L, Ashworth M, Finnoff D, Newbold S. Hesitancy towards a COVID-19 vaccine and prospects for herd immunity;2020.
Available:https://ssrn.com/abstract=3593098 Accessed May 13, 2021.
Jeanette B. Ruiz, Robert A. Bell. Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine. 2021;9(7):1080-1086.
Allagoa DO, Oriji PC, Obagah L, Tekenah ES, Dambo N, Atemie G. Knowledge, Attitudes and Practices towards Covid-19 among pregnant women in a tertiary hospital in South-South, Nigeria. International Journal of Research and Reports in Gynaecology. 2020;3(3):35- 41.
Available:https://www.journalijrrgy.com/index.php/IJRRGY/article/view/30115 Accessed May 13, 2021.
Abstract View: 114 times
PDF Download: 79 times